Russell Investments Group
CLBT icon

Russell Investments Group’s Cellebrite CLBT Stock Holding History

Russell Investments Group’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$248 Buy
+17
New +$225 ﹤0.01% 4233
2025
Q3 		– Sell
-7,218
Closed -$115K – 4162
2025
Q2 		$115K Sell
7,218
-82,594
-92% -$1.47M ﹤0.01% 2785
2025
Q1 		$1.75M Sell
89,812
-60,604
-40% -$1.28M ﹤0.01% 1779
2024
Q4 		$3.31M Buy
150,416
+98,833
+192% +$1.9M ﹤0.01% 1393
2024
Q3 		$869K Buy
+51,583
New +$765K ﹤0.01% 2081
2024
Q2 		– Sell
-16,649
Closed -$188K – 3588
2024
Q1 		$188K Buy
16,649
+8,001
+93% +$81.7K ﹤0.01% 2453
2023
Q4 		$75.2K Hold
8,648
– – ﹤0.01% 2596
2023
Q3 		$65.4K Buy
+8,648
New +$64.9K ﹤0.01% 2708

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Russell Investments Group's CLBT Position: Q2 2026 in Review

Russell Investments Group opened a new position in Cellebrite (CLBT) in Q2 2026: 17 shares worth $248. The stake represents ﹤0.01% of the portfolio and ranks #4233 among its holdings. This is a return to the name: Russell Investments Group previously reported a position in CLBT as recently as Q2 2025.

Russell Investments Group first reported a position in CLBT in Q3 2023 and has held it in 8 quarters since. The position peaked at $3.31M in Q4 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Russell Investments Group held 17 shares of Cellebrite worth $248 as of Q2 2026.
  • Cellebrite was a new Russell Investments Group position in Q2 2026.
  • Cellebrite made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #4233 holding.
  • Russell Investments Group first reported a position in Cellebrite in Q3 2023 and has held it in 8 quarters since.
  • Russell Investments Group's Cellebrite position peaked at $3.31M in Q4 2024.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.